10435-57-1

Basic information

• Product Name: 5-Cyanosalicylic acid
• Synonyms: 5-Cyanosalicylic acid;5-cyano-2-hydroxybenzoic acid
• CAS NO: 10435-57-1
• Molecular Formula: C₈H₅NO₃
• Molecular Weight: 163.1302
• Mol File: 10435-57-1.mol
• Article Data: 19

Chemical Properties

• Boiling Point: 377.5±37.0 °C(Predicted)
• Appearance: /
• Density: 1.50±0.1 g/cm3(Predicted)
• PKA: 2.35±0.10(Predicted)
• CAS DataBase Reference: 5-Cyanosalicylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Cyanosalicylic acid(10435-57-1)
• EPA Substance Registry System: 5-Cyanosalicylic acid(10435-57-1)

Safety Data

• Hazardous Substances Data: 10435-57-1(Hazardous Substances Data)

Usage

General Description

5-Cyanosalicylic acid is a chemical compound with the molecular formula C8H5NO4. It is a derivative of salicylic acid, containing a cyano group (-CN) at the 5-position of the benzene ring. 5-Cyanosalicylic acid is commonly used as a reagent in the synthesis of organic compounds and as a starting material for the production of other chemicals. It has also been studied for its potential pharmaceutical applications, particularly for its anti-inflammatory and antioxidant properties. Additionally, 5-Cyanosalicylic acid has been investigated for its use in analytical chemistry as a reagent for the detection and quantification of various metal ions in solution. Overall, 5-Cyanosalicylic acid has a range of practical and potential applications in industry, pharmaceuticals, and research.

Upstream product

• 179256-31-6 2-benzyloxy-5-cyanobenzoic acid benzyl ester 
• 74901-29-4 5-cyanosalicylaldehyde 
• 767-00-0 4-cyanophenol 
• 119-30-2 2-hydroxy-5-iodobenzoic acid 
• 84437-12-7 methyl 5-cyanosalicylate 
• 544-92-3 copper(I) cyanide 
• 89-55-4 5-bromosalicyclic acid 
• 150258-60-9 benzyl 5-formyl-2-(benzyloxy)benzoate 
• 773837-37-9 sodium cyanide 
• 89-57-6 5-Aminosalicylic Acid 
• 616-76-2 2-hydroxy-5-formylbenzoic acid 

Downstream Products

• 179256-31-6 2-benzyloxy-5-cyanobenzoic acid benzyl ester 
• 518978-03-5 5-cyano-2-[(phenylmethyl)oxy]benzoic acid 
• 1426396-67-9 N-(3,5-bis-trifluoromethyl-phenyl)-2-hydroxy-isophthalamide 
• 97005-33-9 5-cyano-salicylamide 
• 84437-04-7 2-Benzoyloxy-5-carbamimidoyl-benzoic acid 
• 84437-06-9 5-Carbamimidoyl-2-hydroxy-benzoic acid 
• 124071-06-3 N-[3-Chloro-4-(4-chloro-phenoxy)-phenyl]-5-cyano-2-hydroxy-benzamide 
• 84437-08-1 2-Hydroxy-5-methoxycarbonimidoyl-benzoic acid; hydrochloride 
• 67127-54-2 5-cyano-2-hydroxy-N-(1⁽²⁾H-tetrazol-5-yl)-benzamide 

Relevant articles and documents

Synthesis, evaluation and docking studies of some 4-thiazolone derivatives as effective lipoxygenase inhibitors

Some promising 4-thiazolone derivatives as lipoxygenase inhibitors were designed, synthesized, characterized and evaluated for anti-inflammatory activity and respective ulcerogenic liabilities. Compounds (1b, 1e, 3b, and 3e) exhibited considerable in vivo

METHODS OF TREATING CREATINE TRANSPORTER DEFICIENCY

Disclosed are methods of treating creatine transporter deficiency, comprising administering to a mammal in need thereof a therapeutically effective amount of a compound that increases transport of a substrate by a mutant or wild-type creatine transporter. Also disclosed are methods of increasing transport of guanidinoacetic acid or a salt thereof across the blood-brain barrier of a mammal, and methods of decreasing accumulation or the concentration of guanidinoacetic acid or a salt thereof in a mammalian cell.

INDAZOLES AND AZAINDAZOLES AS LRRK2 INHIBITORS

The present invention is directed to indazole and azaindazole compounds which are inhibitors of LRRK2 and are useful in the treatment of CNS disorders.